Beijing Inno Medicine Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2016-11-15
- Employees
- -
- Market Cap
- -
YN001-004 in Patients With Coronary Atherosclerosis in Australia
Phase 2
Recruiting
- Conditions
- Coronary Artery DiseaseCoronary Atherosclerotic Disease
- Interventions
- First Posted Date
- 2024-11-22
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Beijing Inno Medicine Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06700720
- Locations
- 🇦🇺
Canberra Hospital, Canberra, Australian Capital Territory, Australia
🇦🇺Albury Wodonga Private Hospital, Albury, New South Wales, Australia
🇦🇺Core Research Group Pty Ltd, Milton, Queesland, Australia
YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
Phase 1
Completed
- Conditions
- Atherosclerotic Cardiovascular Disease
- Interventions
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Beijing Inno Medicine Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT06048588
- Locations
- 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Peking University first hospital, Beijing, Beijing, China
🇨🇳Renmin Hospital of Wuhan University, Wuhan, Hubei, China
A First-in-human Study of YN001 in Healthy Volunteers
- First Posted Date
- 2022-12-02
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Beijing Inno Medicine Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT05635084
- Locations
- 🇦🇺
Nucleus Network Pty Ltd, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath